{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:20:43Z","timestamp":1789996843205,"version":"4.0.1"},"reference-count":17,"publisher":"American Society for Clinical Investigation","issue":"2","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,17]]},"DOI":"10.1172\/jci164577","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T19:01:06Z","timestamp":1673895666000},"source":"Crossref","is-referenced-by-count":15,"title":["The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors"],"prefix":"10.1172","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9970-8695","authenticated-orcid":false,"given":"Amy B.","family":"Heimberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimas V.","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.028"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2016.02.006"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04502-z"},{"issue":"2","key":"B4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163472","article-title":"Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients","volume":"132","author":"Watne","year":"2022","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.02.001"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.06.022"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010191"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2015.12.009"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00200"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3573"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-2-21"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3874"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)90349-2"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.02.013"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not114"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02767"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/164577\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T17:47:11Z","timestamp":1691084831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/164577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,17]]},"published-print":{"date-parts":[[2023,1,17]]}},"alternative-id":["10.1172\/JCI164577"],"URL":"https:\/\/doi.org\/10.1172\/jci164577","relation":{},"ISSN":["1558-8238"],"issn-type":[{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"article-number":"e164577"}}